Keywords: shire, reveals, once-daily, version, adderall, pharmaceuticals, uk
Shire reveals once-daily version of Adderall
Article | 08 September 2000
Shire Pharmaceuticals of the UK has revealed that it has developed aonce-daily formulation of its attention-deficit hyperactivity disorder treatment Adderall ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
